ArticleEvolutionary applications2026
Integrating Ultimate and Proximate Explanations of Neurodivergence: Evolutionary Trade-Offs, Compensation, and Clinical Expression.
Article in Evolutionary applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Elevated rates of major depressive disorder and anxiety disorders in neurodivergent populations are often interpreted as evidence that autism, attention-deficit/hyperactivity disorder, and affective disorders share intrinsic neurobiological pathology. Evolutionary psychiatry offers a different interpretation: neurodivergent trait profiles may reflect evolutionarily shaped cognitive variation whose consequences depend on ecological and social fit. Recent evolutionary psychiatry work has extended this perspective by interpreting the concomitance of neurodivergence with depression and anxiety through evolutionary trade-off, mismatch, and evolved affective defense systems. Here, this ultimate-level account is integrated with the pathogenetic triad, an operationalized cross-level framework that adds an individual-level account of how traits, adaptive capacity, burden, and environmental demands shape clinical expression. This synthesis suggests one pathway by which depression and anxiety may arise in neurodivergent individuals: chronic mismatch may increase compensatory demands and repeatedly activate evolved affective and defensive systems, particularly when regulatory buffering is limited or burden is high. The resulting framework helps reconcile neurodiversity and medical models by distinguishing natural neurodivergent trait variation from the mechanisms through which it becomes clinically impairing. Evolutionary psychiatry helps explain why neurodivergent traits persist and why mismatch may generate vulnerability; the pathogenetic triad helps specify how, when, and for whom such vulnerability becomes clinically expressed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.